Skip to main content
. 2021 Mar 26;100(12):e25219. doi: 10.1097/MD.0000000000025219

Table 1.

Demographic characteristics of COVID-19 confirmed cases (n = 3827) by age, sex, nationality, and workplace exposure levels, comorbidities, clinical presentation, and outcomes in the Emirate of Abu Dhabi between March 12 and April 22, 2020.

Female (n = 670) Male (n = 3157) Total (N = 3827)
n (%) n (%) N (%) P-value
Age distributions .000a
 <1 17 0% 16 0.4% 33 1%
 1–5 36 1% 29 0.8% 65 2%
 6–10 16 0.4% 22 0.6% 38 1%
 11–18 25 0.7% 31 1% 56 1%
 19–29 156 4% 785 21% 941 25%
 30–39 234 6% 1163 30% 1397 37%
 40–49 113 3% 654 17% 767 20%
 50–59 41 1% 355 9% 396 10%
 60–69 18 0.5% 85 2% 103 3%
 70–79 7 0.2% 11 0.3% 18 0.5%
 80+ 7 0.2% 6 0.2% 13 0.3%
Nationality .000a
 UAE 160 4% 380 10% 540 14%
 Other Arab countries 124 3% 311 8% 435 11%
 Non-Arab countries 381 10% 2434 64% 2815 74%
 Unknown 5 0.1% 32 1% 37 1%
COVID-19 workplace exposure risk levels .000a
 High exposure risk
  Healthcare workers 63 2% 47 1% 110 3%
 Medium exposure risk
  Laborers and workers at high density workplaces 61 2% 567 15% 628 16%
 Lower exposure risk
  Office workers and workers with minimum contact with public 409 11% 2346 61% 2755 72%
  Other 137 4% 197 5% 334 9%
Comorbidities .001a
 No comorbidities 566 15% 2813 74% 3379 88%
 With comorbidities 104 3% 344 9% 448 12%
 Hypertension 13 3% 107 24% 120 27%§
 Diabetes 4 1% 92 21% 96 21%§
 Pregnancy 36 8% - - 36 8%§
 Chronic pulmonary disease 10 2% 12 3% 22 5%§
 Cardiovascular disease 4 1% 14 3% 18 4%§
 Immunocompromised 9 2% 3 1% 12 3%§
 Chronic neurological/Neuromuscular disease 3 1% 6 1% 9 2%§
 Czhronic kidney disease 5 1% 5 1%§
 Chronic liver disease 5 1% 5 1%§
 Two or more comorbidities 25 6% 100 22% 125 28%a
Time interval (date of onset of symptoms—date of notification) mean (SD) 3.8 (3.4) .000a
Clinical presentation .000a
 Asymptomatic cases 236 6% 1407 37% 1643 43%
 Symptomatic cases 434 11% 1750 46% 2184 57%
 Mild 244 11.2% 1033 47.3% 1277 58%
 Cough 31 1.4% 129 5.9% 160 7%
 Fever 22 1.0% 129 5.9% 151 7%
 Headache 1 0.05% 29 1.3% 30 1%
 Sore throat 22 1.0% 83 3.8% 105 5%
 Myalgia 5 0.2% 17 0.8% 22 1%
 Runny nose 9 0.4% 14 0.6% 23 1%
 Arthralgia - - 1 0.05% 1 0.05%
 More than one mild symptom 154 7.1% 631 28.9% 785 36%
 Moderate 110 5.0% 420 19.2% 530 24%
 Abdominal pain 1 0.05% 5 0.2% 6 0.3%
 Vomiting 1 0.05% 1 0.0% 2 0.1%
 Diarrhea 1 0.05% 10 0.5% 11 1%
 Viral pneumonia 40 1.83% 199 9.1% 239 11%
 More than one moderate symptom 67 3.1% 205 9.4% 272 12%
 Severe 40 1.8% 149 6.8% 189 9%
 Shortness of breath 3 0.1% 10 0.5% 13 0.6%
 Chest pain 3 0.1% 5 0.2% 8 0.4%
 Severe viral pneumonia 1 0.05% 2 0.1% 3 0.1%
 More than one severe symptom 33 1.5% 132 6.0% 165 8%
 Critical 10 0.5% 37 1.7% 47 2%
 ARDS 7 0.3% 26 1.2% 33 2%
 Sepsis 3 0.1% 5 0.2% 8 0.4%
 Renal failure - - 6 0.3% 6 0.3%
 Missing symptoms 30 1.4% 111 5.1% 141 6%
Outcome .004a
 Not admitted to hospital 298 8% 1564 41% 1862 49%
 Admitted to hospital 269 7% 1056 28% 1325 35%
 Not admitted to ICU 264 20% 1010 76% 1274 96%#
 Admitted to ICU 5 0.4% 46 3% 51 4%#
 Missing 103 3% 537 14% 640 17%
 Deaths 4 0.1% 4 0.1%∗∗

Percentages may not total 100 because of rounding.

Chi-square test for qualitative variables and t test for quantitative variables were performed to compare male cases to female cases.

UAE = United Arab Emirates, ARDS = acute respiratory distress syndrome, SD = Standard deviation, ICU = intensive care unit.

Including Comoros, Western Sahara Region, and South Sudan.

Housewives, retired elderly, and children aged 0–18 yrs.

§

Percentages were calculated out of 448.

Diabetes and hypertension were the most reported comorbidities (n = 47).

Percentages for symptomatic cases were calculated out of 2184.

#

Percentages were calculated out of 1325.

∗∗

Percentage was calculated out of 3827.

a

Significance level at P-value < .05.